The Accenture Technology Vision 2015 surveyed the opinions of 1000+ C-suite and D-suite executives across industries from around the world about key digital trends and their likely impact. More than 100 senior executives from life sciences firms participated in the survey. Explore how life sciences companies plan to unlock value from these five digital disruptions.
1. The Internet of Me: Healthcare, personalized
This is the era of personalized healthcare, monitoring and treatment that can build trust by enabling meaningful patient experiences. For life sciences companies, there is a major opportunity to engage in the wellness revolution by using apps and wearables to promote general wellness and treatment delay or prevention. Digital technologies also provide new access points that allow businesses to personalize the patient journey. These personalized experiences help to build trust and improve service adoption.
2. Outcome Economy: Hardware producing health results
New intelligence in embedded hardware and sensors is giving patients and healthcare providers better health outcomes. Eighty-five percent of life science respondents believe that more intelligent hardware, sensors and devices on the edge of networks will lead to the industry shifting from selling products to selling outcomes. With competent hardware, it will become easier to personalize care, measure value and target desired outcomes. Digital hardware, including diagnostic apps and smart pills, is also enabling a reinvention of life sciences R&D.
3. The Platform (R)evolution: Defining ecosystems, redefining life science
Digital industry platforms and ecosystems are fuelling the next wave of breakthrough innovation and disruptive growth. For life sciences, we see potential for disruptors to emerge in four key ecosystems: provider, patient, product, and regulatory and reimbursement.
4. Intelligent Enterprise: Huge data, smarter systems, better healthcare solutions
For a data-intensive industry like life science, software must do more than learn and adapt—and it is. Software intelligence will drive new levels of evolution and discovery. Life sciences companies are beginning to take advantage by establishing a data supply chain and investing in software intelligence to improve big data analytical capabilities.
5.Workforce Reimagined: Collaboration at the intersection of humans and healthcare
As the digital revolution gains momentum, scientists and life science professionals are using machines to be more efficient, provide better decisions and take on increasingly more complex tasks. For instance, augmented devices will provide more portability, insights and unprecedented contextual information to scientists, clinicians and doctors during the research, drug development and clinical trials process. Digital also comes into play with training; 74 percent of life sciences respondents believe that companies will need to focus on training their machines as much as they do on training their people.
These trends illustrate that life sciences companies must embrace digital to go beyond the confines of traditional industry, product and customer boundaries to find entirely new ways to meet customer needs.For more information, read our 2015 Life Sciences Technology Vision.